TGFB1 and glioma: Next, TGF-β irreversibly inhibits the cytotoxic function of NK cells by inducing changes in their phenotype, transcription factors, cytotoxic molecules, and chemokines, thus helping GSCs evade NK cells and contributing to the progression of glioma (Shaim et al., 2021).